NTI — Neurotech International Income Statement
0.000.00%
Last trade - 00:00- AU$29.18m
- AU$23.22m
- AU$3.34m
Annual income statement for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.082 | 0.206 | 0.608 | 1.25 | 3.34 |
| Cost of Revenue | |||||
| Gross Profit | 0.027 | 0.227 | 0.601 | 1.25 | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.37 | 7.65 | 3.97 | 9.05 | 8.4 |
| Operating Profit | -1.29 | -7.45 | -3.36 | -7.79 | -5.07 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.71 | -7.43 | -3.36 | -7.79 | -5.07 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.71 | -7.43 | -3.36 | -7.79 | -5.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.71 | -7.43 | -3.36 | -7.79 | -5.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.71 | -7.43 | -3.36 | -7.79 | -5.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.011 | -0.015 | -0.005 | -0.01 | -0.006 |